AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FACTEUR VIII
25 registrations across 2 African markets— 4 active
Markets with FACTEUR VIII
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| REFACTO AF 1000UI Pdre p.prep.injectable / 1000 UI | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Jul 2021 |
| REFACTO AF Pdre p.prep.injectable / 250 UI | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Jun 2021 |
| REFACTO AF Pdre p.prep.injectable / 500 UI | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Jun 2021 |
| NOVO EIGHT Pdre p.prep.injectable / 250UI | 🇹🇳Tunisia | NOVO NORDISK A/S Bagsvaerd | expired | Mar 2018 |
| NOVO EIGHT Pdre p.prep.injectable / 1000UI | 🇹🇳Tunisia | NOVO NORDISK A/S Bagsvaerd | expired | Mar 2018 |
| NOVO EIGHT Poudre pour suspension injectable / 500UI | 🇹🇳Tunisia | NOVO NORDISK A/S Bagsvaerd | expired | Mar 2018 |
| BERIATE Poudre pour solution injectable / 250 UI | 🇹🇳Tunisia | CSL BEHRING GmbH | expired | Mar 2018 |
| BERIATE Poudre pour solution injectable / 500 UI | 🇹🇳Tunisia | CSL BEHRING GmbH | expired | Mar 2018 |
| REFACTO AF 1000UI Pdre p.prep.injectable / 1000 UI | 🇹🇳Tunisia | PFIZER Limited UK | expired | Aug 2015 |
| OCTANATE 50 UI/ML Pdre p.prep.injectable / 500 UI | 🇹🇳Tunisia | OCTAPHARMA pharmazeutika produktionges.m.b.h | expired | Jan 2015 |
| OCTANATE 50 UI/ML Pdre p.prep.injectable / 250 UI | 🇹🇳Tunisia | OCTAPHARMA pharmazeutika produktionges.m.b.h | expired | Jan 2015 |
| EMOCLOT Pdre p.prep.injectable / 500 UI/10 ml | 🇹🇳Tunisia | KEDRION S.p.A | expired | Aug 2013 |
| KOGENATE -FS Pdre p.prep.injectable / 250 UI | 🇹🇳Tunisia | BAYER CORPORATION | expired | Apr 2010 |
| KOGENATE -FS Pdre p.prep.injectable / 500 UI | 🇹🇳Tunisia | BAYER CORPORATION | expired | Nov 2009 |
| KOGENATE -FS Pdre p.prep.injectable / 1000 UI | 🇹🇳Tunisia | BAYER CORPORATION | expired | Aug 2009 |
| OCTANATE 50 UI/ML Pdre p.prep.injectable / 500 UI | 🇹🇳Tunisia | OCTAPHARMA AG SUISSE | expired | Aug 2005 |
| OCTANATE 100 UI/ML Pdre p.prep.injectable / 1000 UI | 🇹🇳Tunisia | OCTAPHARMA AG SUISSE | expired | Aug 2005 |
| HAEMOCTIN SDH 500 Pdre p.prep.injectable / 50 UI/ml | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Apr 2004 |
| HAEMOCTIN SDH 250 Pdre p.prep.injectable / 50 UI/ml | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Apr 2004 |
| FACTANE 100 UI/ML Pdre p.prep.injectable / 100 UI/ml | 🇹🇳Tunisia | LFB-Biomédicaments | expired | Jun 2003 |
| FACTANE 100 UI/ML Pdre p.prep.injectable / 500 UI | 🇹🇳Tunisia | LFB-Biomédicaments | expired | Jun 1998 |
| FACTEUR VIII DE COAGULATION HUMAIN-CNTS 100 UI/ML POUDRE ET SOLVANT POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| OCTANATE 100 UI/ML POUDRE ET SOLVANT POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| OCTANATE 50 UI/ML POUDRE ET SOLVANT POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| OCTANATE 50 UI/ML POUDRE ET SOLVANT POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
FACTEUR VIII in Africa — Regulatory Overview
FACTEUR VIII is registered across 2 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.
Of the 25 registrations, 4 (16%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.